Suspicious diagnosis of epithelial ovarian cancer (subsequent histologically confirmation required)
Plan to undergo a surgical procedure for the management of epithelial ovarian cancer or recurrent ovarian cancer previously treated with conventional treatment and involved in the trial as group A-D
≥18 years old
ECOG Performance Status ≤ 2
Written informed consent
Indication for adnexectomy for a benign gynecological condition
≥18 years old
ECOG Performance Status ≤ 2
Written informed consent
You may not be if
Other active concomitant neoplasms that might confound the results of the planned analysis.
Ongoing active autoimmune disease requiring treatment or condition of immune deficiency
Ongoing chronic treatment with steroids or other immune suppressive agents at the time of study entry
Clareo Health | The Immune Landscape of Epithelial Ovarian Cancer
